Kronos Bio, Inc.
Kronos Bio, Inc.（KRON）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
kron · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2025年8月8日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$2.25
Consensus
$1.63
+85.2% upside
Low
$1.00
Median: $1.625 · Last Close: $0.88
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$1.63
85.2% upside
High Target
$2.25
155.7%
Low Target
$1
13.6%
Current Price
$0.88
as of today
Based on analyst price targets, the KRON stock price prediction for the next 12 months ranges from $1 to $2.25. The consensus KRON price forecast of $1.63 implies 85.2% upside from the current price of $0.88.
短期股价预测
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KRON · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-08-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-12-19 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-11-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-04-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-11-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-11-10 | Goldman Sachs | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kronos Bio, Inc. (KRON) stock. Of the recent 20 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover KRON.
分析师推荐趋势
KRON analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$10M
↓ 22.1% YoY
Revenue Next Year
$2M
↓ 78.3% YoY
EPS This Year
$-1.30
EPS Next Year
$-1.30
↑ 0.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast KRON EPS of $-1.30 for the current fiscal year, based on estimates from 1 analysts. The KRON revenue forecast is $10M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KRON 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KRON 的共识目标价为 $1.63（+85.2% 上行空间），分析师共识为 Buy。
Kronos Bio, Inc. 在 NASDAQ 上市，代码 KRON。KRON 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
KRON 预测 · 8 个问题根据 5 位华尔街分析师，KRON 的 12 个月平均目标价为 $1.63，最高 $2.25、最低 $1.00。若有图表，中位目标价可在上方查看。相对当前价 $0.88，隐含约 +85.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.